法瑞西单抗
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
CAS1607793-29-2
Storage conditionstore at -20°C
Security information
Product details

Faricimab is a pioneering humanized bispecific antibody that targets both VEGF-A and Ang-2, offering a dual inhibition approach for retinal diseases like DME and nAMD. By inhibiting VEGF-A, it reduces endothelial cell proliferation and vascular permeability, while blocking Ang-2 is believed to enhance vascular stability and counteract VEGF-A effects. Faricimab has demonstrated a significant reduction in annual injections compared to other anti-VEGF treatments, with a comparable efficacy and safety profile, positioning it as a valuable treatment option for patients with retinal diseases.


Related
Sorry, no related items
History
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)